Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: BeOne Medicines Ltd., 3 years.
BeOne Medicines Ltd.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BeOne Medicines Ltd. June 11, 202698.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | BeOne Medicines Ltd. | Grant or award | +18,980 | — | — |
| May 22, 2026 | BeOne Medicines Ltd. | Open-market sale | −212 | $309.60 | $65,635 |
| May 14, 2026 | Whitehawk Therapeutics Inc. | Grant or award | +19,132 | $3.92 | $74,997 |
| Oct 16, 2025 | Schrodinger Inc. | Open-market sale | −1,395 | $21.07 | $29,393 |
| May 21, 2025 | BeOne Medicines Ltd. | Grant or award | +10,985 | — | — |
| Mar 3, 2025 | Schrodinger Inc. | Grant or award | +12,500 | — | — |
| Oct 15, 2024 | Schrodinger Inc. | Open-market sale | −1,531 | $17.78 | $27,221 |
| Jun 5, 2024 | BeOne Medicines Ltd. | Grant or award | +16,341 | — | — |
| Aug 9, 2023 | Schrodinger Inc. | Grant or award | +15,000 | — | — |
| Jun 15, 2023 | BeOne Medicines Ltd. | Grant or award | +12,922 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.